Jay Finechem Private Limited
About Jay Finechem Private Limited
Data last updated:
Jay Finechem Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 07 June 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21001MH2023PTC404466. Its GSTIN is 24AAGCJ0379L1ZC (Gujarat).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Naresh Kanji Dama and Uma Naresh Dama.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹145.44 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹19.76 Cr (net margin 13.6%) and EBITDA of ₹31.96 Cr (EBITDA margin 22%).
As per MCA filings, the company has open charges of ₹25.37 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Company details
Contact details
Jay Finechem Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address03 C Neelkanth Business, Park Vidyavihar W, Mumbai, Maharashtra, India – 400086
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jay Finechem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Jay Finechem Private Limited, buy the company report.
Financials of Jay Finechem Private Limited
FY 2025 filings availableJay Finechem Private Limited reported revenue of ₹145.44 Cr (up 187% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 187% in the latest year. EBITDA rose 482% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹31.96 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹19.76 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 22% | |
| Net Profit Margin | 13.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Jay Finechem Private Limited, buy the company report.
Board of directors of Jay Finechem Private Limited
Jay Finechem has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Kanji Dama | Director | 07 Jun 2023 | 3 Years 4 Months | Current |
| Uma Naresh Dama | Director | 07 Jun 2023 | 3 Years 4 Months | Current |
| Shruti Amrut Dama Also directs: Hari Innovation Labs LLP | Director | 07 Jun 2023 | 3 Years 4 Months | Current |
| Meena Amrut Dama Also directs: Punagri Organics and Lifesciences Private Limited | Director | 07 Jun 2023 | 3 Years 4 Months | Current |
| Amrutkumar Dama Kanji Also directs: Punagri Organics and Lifesciences Private Limited | Director | 07 Jun 2023 | 3 Years 4 Months | Current |
Peer comparison
Jay Finechem Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Therapiva Private Limited | ₹148.94 Cr (FY 2021) | -23.0% | Secunderabad, Telangana, India | |||
| Unimark Remedies Limited | ₹148.77 Cr (FY 2018) | -19.0% | Mumbai, Maharashtra, India | |||
| Atlas Life Sciences Private Limited | ₹148.18 Cr (FY 2022) | 35.0% | Ahmedabad, Gujarat, India | |||
| Sionc Pharmaceuticals Private Limited | ₹147.51 Cr (FY 2024) | 13.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Jay Finechem Private Limitedthis company | ₹145.44 Cr (FY 2025) | ₹19.76 Cr | 13.6% | 187.0% | Mumbai, Maharashtra, India | |
| Lyka Labs Limited | ₹140.73 Cr (FY 2025) | 25.0% | Ankleshwar, Gujarat, India | |||
| Azico Biophore India Private Limited | ₹140.48 Cr (FY 2024) | 25.0% | Hyderabad, Telangana, India | |||
| Silicon Life Sciences Private Limited | ₹139.2 Cr (FY 2020) | 31.0% | Hyderabad, Telangana, India | |||
| Satyadeeptha Pharmaceuticals Limited | ₹138.74 Cr (FY 2025) | -31.0% | Humnabad, Karnataka, India |
To see the full peer comparison of Jay Finechem Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 May 2025 | 101094633 | Hdfc Bank Limited | ₹7 Lakh | Open | |
| 03 May 2025 | 101092013 | Hdfc Bank Limited | ₹11.6 Lakh | Open | |
| 20 Dec 2024 | 101019809 | Hdfc Bank Limited | ₹18.35 Lakh | Open | |
| 20 Aug 2024 | 100967883 | Citi Bank N.A. | ₹25 Cr | Open |
Total charge records: 4 View all charges
Legal cases
Jay Finechem Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Valsad, Gujarat | Court case (REFER-T-LC) | Filed against the company by an individual | Pending |
To see the full case history of Jay Finechem Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jay Finechem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jay Finechem has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCJ0379L1ZC | Gujarat | Active | 03 Aug 2023 |
To see the full GST registrations and return filing status of Jay Finechem Private Limited, buy the company report.
Recent activity
Jay Finechem Private Limited has 5 board changes on record since 2023: 5 appointments. The latest: Amrutkumar Dama Kanji was appointed as Director on 07 Jun 2023.
Frequently asked questions
Jay Finechem is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 07 June 2023 (3+ years old) and is registered under CIN U21001MH2023PTC404466.
Jay Finechem has 5 current directors:
- Naresh Kanji Dama - Director
- Uma Naresh Dama - Director
- Shruti Amrut Dama - Director
- Meena Amrut Dama - Director
- Amrutkumar Dama Kanji - Director
The latest financial statements of Jay Finechem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Jay Finechem is 24AAGCJ0379L1ZC, registered in Gujarat.
The CIN (Corporate Identification Number) of Jay Finechem is U21001MH2023PTC404466. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jay Finechem has 1 court case on record: 1 filed against it. 1 is pending.
Jay Finechem was incorporated on 07 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Jay Finechem by revenue are Therapiva Private Limited, Unimark Remedies Limited, Atlas Life Sciences Private Limited, Sionc Pharmaceuticals Private Limited, Lyka Labs Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amrutkumar Dama Kanji was appointed as Director on 07 Jun 2023. Meena Amrut Dama was appointed as Director on 07 Jun 2023. Naresh Kanji Dama was appointed as Director on 07 Jun 2023. Jay Finechem has 5 board changes on record in total.
The registered office of Jay Finechem is at 03 C Neelkanth Business, Park Vidyavihar W, Mumbai, Maharashtra, India – 400086.
Jay Finechem operates in the pharma industry, in the api manufacturers segment.